News and Trends 5 May 2023
Exothera partners with Quantoom and launches DNA business unit
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The…
Vaccines
- Latest Posts
News and Trends 4 May 2023
World’s first RSV vaccine for older adults gets FDA approval
GSK plc says the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the…
Sponsored by Quantoom Biosciences
4 May 2023How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production?
Quantoom Biosciences has just launched Ntensify™, the world’s first continuous mRNA production technology that is set to revolutionize the entire…
In Depth 3 May 2023
Immunotherapy in the fight against solid tumors
Ever since William Coley first attempted to harness the immune system in 1891 to treat bone cancer, immunotherapy has been…
ADVERTISEMENT
In Depth 26 Apr 2023
Vaccine for honeybees: a new hope for American foulbrood disease
In the last few years, there has been an ongoing movement to ‘save the bees’, and the U.S. biotech Dalan…
News and Trends 26 Apr 2023
aVaxziPen’s needle-free vaccine yields positive data across multiple diseases
aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in…
News and Trends 26 Apr 2023
Global partners announce The Big Catch-up vaccination effort
WHO, UNICEF, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation, along with Immunization Agenda 2030 and many…
Opinion 26 Apr 2023
Can mRNA vaccines tackle multiple diseases?
By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week…
Opinion 26 Apr 2023
How to address declining vaccination rates in older adults
By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last…
News and Trends 26 Apr 2023
20Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform
20Med Therapeutics, a company working on non-viral delivery and development of gene therapies and vaccines, and Touchlight, a biotechnology company…
More News! 25 Apr 2023
More efficient and cost-effective mRNA vaccines developed
A new and patented method for the production of the important mRNA vaccine component pseudouridine is more efficient, sustainable and…
In Depth 19 Apr 2023
How Vaccine Platforms Can Prepare Us for Future Pandemics
The COVID-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be powerful tools for reacting faster to future…
Expert Advice 18 Apr 2023
Pharmacovigilance – how to deal with the data
By Axel Hagel, practice leader, PV & RM services, IQVIA Life science data, especially safety data, is exploding. Axel Hagel,…
News and Trends 17 Apr 2023
Ghana becomes first country to approve University of Oxford malaria vaccine
Ghana has granted full national licensure for the University of Oxford’s R21/Matrix-M malaria vaccine, marking the first regulatory clearance for…
In Depth 14 Apr 2023
mRNA vaccines: a promising future
In 1978, nearly two decades after the discovery of messenger RNA (mRNA), the concept of a vaccine made from mRNA…
News and Trends 13 Apr 2023
Parkinson’s cure ‘inevitable’ after biomarker breakthrough
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced what it says is the ‘most significant breakthrough yet’…
ADVERTISEMENT
Best in Biotech 12 Apr 2023
6 new vaccines being developed for difficult-to-treat diseases
There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find…
In Depth 11 Apr 2023
Is a vaccine for Parkinson’s disease possible?
Finding a truly effective treatment for Parkinson’s disease - that goes beyond simply managing symptoms - has long been a…
Best in Biotech 6 Apr 2023
Cancer vaccines: 10 biotech companies that have changed the game
A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered…
News and Trends 4 Apr 2023
Alzamend pushing ahead with Alzheimer’s vaccine trial
Alzamend Neuro, Inc. has announced the initiation of a phase I/IIA clinical trial for its immunotherapy vaccine (ALZN002) to treat…
